查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1391170

2024 年藥物篩選全球市場報告

Drug Screening Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，藥物篩選的市場規模迅速擴大。將從2023年的76.5億美元擴大到2024年的87.9億美元，複合年成長率為14.9%。實績期間的成長是由於藥物測試、醫療和臨床診斷、藥物濫用治療、研發投資以及藥物檢測套組和設備的使用增加所推動的。

藥物篩選市場的成長預計將受到藥物和酒精消費量增加的推動。毒癮是病理，導致無法控制合法或非法物質（如酒精、大麻或尼古丁）的使用。隨著藥物和酒精成癮的增加，相關的健康風險也隨之增加，因此需要進行藥物篩檢。 2022 年，全球對毒品和酒精消費的擔憂依然存在，國家毒品使用與健康調查 (NSDUH) 報告稱，12 歲及以上美國人的毒品使用量與前一年同期比較成長 3.8%。另據報導，21.4%的同儕在過去一年內使用過非法藥物或濫用處方箋藥。持續的疫情進一步加劇了毒品風險，某些地區年輕人的大麻消費量增加了四倍。毒品和酒精消費量的增加極大地促進了藥物篩選市場的成長。

2023年藥物篩選市場最大的地區是北美。預計亞太地區將成為預測期內藥物篩選市場成長最快的地區。藥物篩選市場報告涵蓋的地區包括亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

目錄

第1章執行摘要

第2章 藥物篩選市場特點

第3章藥物篩選市場趨勢與策略

第4章藥物篩選市場－宏觀經濟情勢

第5章 全球藥物篩選市場規模及成長

  • 全球藥物篩選市場的驅動與抑制因素
    • 市場驅動力
    • 市場抑制因素
  • 2018-2023年全球藥物篩選市場規模實績與成長
  • 2023-2028、2033年全球藥物篩選市場規模及成長預測

第6章藥物篩選市場區隔

  • 全球藥物篩選市場，依產品區隔，實績與預測，2018-2023、2023-2028、2033
  • 快速檢測裝置
  • 消耗品
  • 其他產品
  • 全球藥物篩選市場，依樣本類型區隔、實績和預測，2018-2023、2023-2028、2033
  • 口腔液樣本
  • 頭髮樣本
  • 尿液樣本
  • 呼吸樣本
  • 其他樣品類型
  • 全球藥物篩選市場，依最終用戶區隔，實績和預測，2018-2023、2023-2028、2033
  • 藥物檢測實驗室
  • 職場
  • 刑事司法和執法
  • 醫院
  • 戒毒治療中心
  • 個人用戶
  • 疼痛管理中心
  • 學校和大學

第 7 章藥物篩選市場區域與國家分析

  • 全球藥物篩選市場，依地區、實績和預測，2018-2023、2023-2028、2033
  • 全球藥物篩選市場，依國家、實績及預測，2018-2023、2023-2028、2033

第8章亞太藥物篩選市場

第9章 中國藥物篩選市場

第10章 印度藥物篩選市場

第11章 日本藥物篩選市場

第12章 澳洲藥物篩選市場

第13章 印尼藥物篩選市場

第14章韓國的藥物篩選市場

第15章 西歐藥物篩選市場

第16章英國藥物篩選市場

第17章 德國藥物篩選市場

第18章 法國藥物篩選市場

第19章 義大利藥物篩選市場

第20章 西班牙藥物篩選市場

第21章 東歐藥物篩選市場

第22章 俄羅斯藥物篩選市場

第23章北美物體篩檢市場

第24章美國藥物篩選市場

第25章加拿大藥物篩選市場

第26章南美洲藥物篩選市場

第27章 巴西藥物篩選市場

第28章 中東藥物篩選市場

第29章 非洲藥物篩選市場

第30章藥物篩選市場競爭形勢及公司概況

  • 藥物篩選市場競爭形勢
  • 藥物篩選市場公司概況
    • Laboratory Corporation
    • Quest Diagnostics Incorporated
    • Alere Inc.
    • OraSure Technologies Inc.
    • Alfa Scientific Designs Inc.

第31章 全球藥物篩選市場競爭基準化分析

第32章全球藥物篩選市場競爭儀錶板

第33章 藥物篩選市場重大併購

第34章藥物篩選市場未來展望及潛力分析

第35章附錄

簡介目錄
Product Code: r9530

“Drug Screening Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug screening? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The drug screening market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Products: Rapid Testing Devices; Consumables; Other Products
  • 2) By Sample Type: Oral Fluid Sample; Hair Sample; Urine Sample; Breath Sample; Other Sample Types
  • 3) By End User: Drug Testing Laboratories; Workplaces; Criminal Justice and Law Enforcement Agencies; Hospitals; Drug Treatment Centers; Individual Users; Pain Management Centers; Schools and Colleges
  • Companies Mentioned: Laboratory Corporation; Quest Diagnostics Incorporated; Alere Inc.; OraSure Technologies Inc.; Alfa Scientific Designs Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Drug screening is an approach used for drug testing, specifically designed and optimized for clinical trials. It involves the analysis of blood, urine, hair, or saliva to detect the presence of chemicals, pollutants, and other illicit substances left in the body due to drug usage.

The main types of drug screening products include rapid testing devices, consumables, and other related items. Rapid testing devices are user-friendly screening tools that provide quicker results compared to traditional laboratory tests. Various samples, such as oral fluid, hair, urine, breath, and others, are used in drug screening. These screenings find applications in drug testing laboratories, workplaces, criminal justice and law enforcement, hospitals, drug treatment centers, individual users, pain management centers, schools, and colleges.

The drug screening market research report is one of a series of new reports from The Business Research Company that provides drug screening market statistics, including drug screening industry global market size, regional shares, competitors with a drug screening market share, detailed drug screening market segments, market trends and opportunities, and any further data you may need to thrive in the drug screening industry. This drug screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug screening market size has grown rapidly in recent years. It will grow from $7.65 billion in 2023 to $8.79 billion in 2024 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to pharmaceutical drug testing, healthcare and clinical diagnostics, substance abuse treatment, research and development investments, and the increasing use of drug testing kits and devices.

The drug screening market size is expected to see rapid growth in the next few years. It will grow to $15.04 billion in 2028 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to the legalization of cannabis and the opioid crisis, increasing sports events, point-of-care and rapid testing, evolving drug policies and regulations, growing workplace wellness and health programs, and international market expansion. Major trends in the forecast period include advanced drug detection technologies, telemedicine and remote testing, research and development investments, innovative drug testing kits and devices, and technological advancements in testing.

The growth of the drug screening market is expected to be driven by the increasing prevalence of drug and alcohol consumption. Drug addiction, a condition affecting both brain and behavior, leads to the inability to control the use of legal or illegal substances such as alcohol, marijuana, and nicotine. As drug and alcohol addiction rise, the associated health risks also increase, necessitating the demand for drug screening. In 2022, global concerns about drug and alcohol consumption persisted, with the National Survey on Drug Use and Health (NSDUH) reporting a 3.8% year-over-year increase in drug use among Americans aged 12 and over. The report also highlighted that 21.4% of people in the same age group had used illegal drugs or misused prescription drugs in the past year. The ongoing pandemic further exacerbated drug risks, with youth cannabis intake increasing up to four times in certain regions. The escalating drug and alcohol consumption significantly contribute to the growth of the drug screening market.

The growth trajectory of the drug screening market is further fueled by the increasing need for the treatment of substance abuse. Substance abuse, characterized by the harmful use of substances, necessitates the identification of compounds not normally present in the body through drug screening. The process involves a screening test followed by a confirmatory test to detect and validate the presence of substances. In June 2021, the United Nations Office on Drugs and Crime (UNODC) reported that over 275 million people worldwide used drugs in the last year, with more than 36 million suffering from drug use disorders. This growing demand for substance abuse treatment is a key driver propelling the growth of the drug screening market.

A notable trend in the drug screening market is the launch of innovative products. Major companies in this sector are actively developing and introducing innovative products to meet the rapidly growing industry demand and enhance their market positions. The COVID-19 pandemic prompted a shift in drug screening approaches, fostering innovation and new product development. Companies are striving to create more effective and widely applicable drug tests for laboratory use. For example, in September 2022, Sysmex Corporation, a Japan-based healthcare company, launched the UF-1500 Fully Automated Urine Particle Testing Analyzer. This innovative product, designed for urine sediment testing and screening, inherits the functionality and usability of the UF-5000 Fully Automated Urine Particle Analyzer while achieving a downsizing of the former model, exemplifying the trend of innovative product launches in the drug screening market.

Companies in the drug screening market are increasingly turning their attention to strategic partnerships and collaborations as a means to enhance their financial strength, fortify their product portfolios, and extend their geographical reach. Strategic collaborations involve agreements between two or more parties to jointly pursue agreed-upon objectives while maintaining their independence as organizations. An illustrative example occurred in December 2022 when PhoreMost Ltd., a UK-based biopharmaceutical company, and ThinkCyte K.K., a Japan-based biotechnology company, announced a strategic research partnership focused on advancing modern phenotypic drug screening through the application of artificial intelligence (AI). This collaboration integrates PhoreMost's SITESEEKER platform, designed to identify optimal new targets for future therapies, with ThinkCyte's Ghost Cytometry technology-a platform leveraging AI for cell characterization and sorting. By combining these innovative technologies, the partnership aims to improve the efficiency and effectiveness of phenotypic drug screening. The collaboration has the potential to identify novel drug targets and facilitate the development of effective therapeutics by leveraging AI and machine learning.

In April 2022, Saladax Biomedical, Inc., a US-based company specializing in the development, manufacturing, and marketing of assays providing rapid therapeutic drug levels, acquired a patent portfolio for antipsychotic drug testing and screening from Janssen Pharmaceutica NV, a Belgium-based pharmaceutical company. This acquisition enabled Saladax to develop tests compatible with chemistry analyzers commonly found in hospitals and a point-of-care instrument suitable for settings where centralized testing is not feasible. These tests address a significant unmet clinical need for patients with serious mental illness (SMI) by delivering rapid and actionable results to healthcare professionals. The collaboration exemplifies how strategic acquisitions contribute to addressing clinical needs and expanding the offerings in the drug screening market.

Major companies operating in the drug screening market include Laboratory Corporation, Quest Diagnostics Incorporated, Alere Inc., OraSure Technologies Inc., Alfa Scientific Designs Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Dragerwerk AG & Co. KGaA, LifeLoc Technologies Inc., MPD Inc., Omega Laboratories Inc., Premier Biotech Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd., Shimadzu Corporation, Siemens Healthineers AG, Medtox Scientific Inc., American Screening Corporation, Clinical Reference Laboratory Inc., Express Diagnostics International Inc., Global Drug Testing Services, Kroll Laboratory Specialists Inc., LabOne Inc., Medscreen Laboratories, National Screening Centers Inc., American Bio Medica Corporation, Mayo Clinic Laboratories, ACM Global Laboratories, Intertek Group plc, Eurofins Scientific SE

North America was the largest region in the drug screening market in 2023. Asia-Pacific is expected to be the fastest-growing region in the drug screening market during the forecast period. The regions covered in the drug screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the drug screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The drug screening market consists of sales of testing kits, reagents, and other supplies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Drug Screening Market Characteristics

3. Drug Screening Market Trends And Strategies

4. Drug Screening Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Drug Screening Market Size and Growth

  • 5.1. Global Drug Screening Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Drug Screening Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Drug Screening Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Drug Screening Market Segmentation

  • 6.1. Global Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Rapid Testing Devices
  • Consumables
  • Other Products
  • 6.2. Global Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral Fluid Sample
  • Hair Sample
  • Urine Sample
  • Breath Sample
  • Other Sample Types
  • 6.3. Global Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Drug Testing Laboratories
  • Workplaces
  • Criminal Justice and Law Enforcement Agencies
  • Hospitals
  • Drug Treatment Centers
  • Individual Users
  • Pain Management Centers
  • Schools and Colleges

7. Drug Screening Market Regional And Country Analysis

  • 7.1. Global Drug Screening Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Drug Screening Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Drug Screening Market

  • 8.1. Asia-Pacific Drug Screening Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Drug Screening Market

  • 9.1. China Drug Screening Market Overview
  • 9.2. China Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Drug Screening Market

  • 10.1. India Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Drug Screening Market

  • 11.1. Japan Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. Japan Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Drug Screening Market

  • 12.1. Australia Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Drug Screening Market

  • 13.1. Indonesia Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Drug Screening Market

  • 14.1. South Korea Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. South Korea Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Drug Screening Market

  • 15.1. Western Europe Drug Screening Market Overview
  • 15.2. Western Europe Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Drug Screening Market

  • 16.1. UK Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Drug Screening Market

  • 17.1. Germany Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Drug Screening Market

  • 18.5. France Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Drug Screening Market

  • 19.9. Italy Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Drug Screening Market

  • 20.13. Spain Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Drug Screening Market

  • 21.1. Eastern Europe Drug Screening Market Overview
  • 21.2. Eastern Europe Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Drug Screening Market

  • 22.1. Russia Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Drug Screening Market

  • 23.1. North America Drug Screening Market Overview
  • 23.2. North America Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Drug Screening Market

  • 24.1. USA Drug Screening Market Overview
  • 24.2. USA Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Drug Screening Market

  • 25.1. Canada Drug Screening Market Overview
  • 25.2. Canada Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Drug Screening Market

  • 26.1. South America Drug Screening Market Overview
  • 26.2. South America Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Drug Screening Market

  • 27.1. Brazil Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Drug Screening Market

  • 28.1. Middle East Drug Screening Market Overview
  • 28.2. Middle East Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Drug Screening Market

  • 29.1. Africa Drug Screening Market Overview
  • 29.2. Africa Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Drug Screening Market Competitive Landscape And Company Profiles

  • 30.1. Drug Screening Market Competitive Landscape
  • 30.2. Drug Screening Market Company Profiles
    • 30.2.1. Laboratory Corporation
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Quest Diagnostics Incorporated
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Alere Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. OraSure Technologies Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Alfa Scientific Designs Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Drug Screening Market Competitive Benchmarking

32. Global Drug Screening Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Drug Screening Market

34. Drug Screening Market Future Outlook and Potential Analysis

  • 34.1 Drug Screening Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Drug Screening Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Drug Screening Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer